Blog

Economic Outlook

The second quarter of 2020 was one for the history books. COVID-19 caused a global pandemic that led to deaths in more Americans than the wars of Vietnam, Korea, and the Gulf Wars combined, and led to “stay-at-home” mandates that caused a sharp, deep recession in Q2 when nearly 20% of Americans were unemployed.1 In May and early June, after many thought the curve of new coronavirus cases had been successfully flattened, economic reopening occurred across the country. Within weeks the virus spread, however, and the US entered the July 4th weekend reporting record numbers of new cases of over 50k/day.1 This is double the rate seen in mid-May with total cases now totaling 2.8m, up from 200k cases at the end of Q1.1 Reopening plans have been rolled back in many states. Generally, the level of uncertainty regarding the virus is growing, not falling.
 
Despite this environment, risk assets enjoyed strong rallies throughout the quarter, leading to discussions of the disconnect between Main Street and Wall Street. Backed by massive monetary stimulus from the Federal Reserve, fiscal stimulus from the Treasury, some early success in the reopening and hopes for a vaccine, US stocks had their best quarter since the fourth quarter of 2008.1 US stocks were again led by the large-cap Technology and other popular growth stocks, leading to concerns of narrowing market leadership that has some resemblance to the dot.com period of the late-90’s. 

After falling 35% in a matter of weeks before bottoming in March, the S&P 500 Index gained 20.5% in the quarter, its best quarter since 1998.1 Reopening was met with early success as a number of economic indicators were better-than-feared in May and June, including two monthly Nonfarm Payroll reports, as the recent report for June showed unemployment levels falling to 11.3% while 4.8m new jobs were filled.1 Hopes for a V-shaped recovery were also boosted by a strong Retail Sales report in May, 1 leading many to believe the sharp recession that occurred in Q2 could be the shortest on record. 

With some progress reportedly being made on several treatments and potential vaccines, many market participants have started pricing risk assets as if the worst of the virus’ impact is over. This was before the onset of what many are calling the “2nd wave” of new coronavirus cases that occurred in mid-June, and before steps had been taken by many states to reverse reopening plans. With expectations that the Federal Reserve will do “whatever it takes” to support the economy and risk assets, investor attention has turned to Congress, as the $600 weekly unemployment benefit from the Federal Government expires on July 31st.1 The passage of another fiscal stimulus bill is an uncertainty entering Q3, but one that is increasingly likely.

The longest-running bull market in history ended in Q1 of 2020 and the shortest-ever recession likely ended in Q2 of this year. Both led to predictable large gains and losses in equities, leaving large-cap US stocks nearly unchanged for the year. While there are still losses in small-cap stocks and non-US stocks, equities have largely already discounted a strong recovery, though the discovery of a vaccine is probably still not discounted. This strikes us as very optimistic. Stocks are expensive and risks are higher now than pre-COVID (more debt, fewer earnings, more uncertainty), but many market pundits feel investors have little choice but to own equities in a zero-interest rate environment where credit spreads are near record lows. We would expect a sharp rally in stocks should a vaccine be announced in the back half of the year, but short of that, we expect future gains to be modest given the starting point of high valuation. 
References: 1. Factset 7/8/20

Most Recent

Economic Commentary 2020Q3

By Lineweaver Financial Group
July 16, 2020 Category: Economic Commentary, 2020Q3

Summer is here: Making lemonade out of lemons The great poet Ralph Waldo Emerson famously wrote, Do what we can, summer will have its flies. As we head into the summer months, this mood may best describe nervous investors who recently experienced large bouts of market volatility due to the spread of the coronavirus. The SP 500 Index fell 34% from its all-time high reached on February 19 to its low on March 23. While it has recovered since then, we are seeing global economic activity reflects the implementation of mandatory shelter-in-place policies. Simultaneously, extreme moves in the oil market with West Texas Intermediate (WTI) oil futures prices at one point trading in negative territory due to fears of oversupply caused additional distress in markets. Globally, central banks and governments stepped up to provide unprecedented levels of stimulus measures on both the monetary policy and fiscal fronts. We see three investment implications from this stimulus. First, we would like

Economic Outlook

By Lineweaver Financial Group
July 16, 2020 Category: Economic Outlook, Q3, 2020

The second quarter of 2020 was one for the history books. COVID-19 caused a global pandemic that led to deaths in more Americans than the wars of Vietnam, Korea, and the Gulf Wars combined, and led to stay-at-home mandates that caused a sharp, deep recession in Q2 when nearly 20% of Americans were unemployed.1 In May and early June, after many thought the curve of new coronavirus cases had been successfully flattened, economic reopening occurred across the country. Within weeks the virus spread, however, and the US entered the July 4th weekend reporting record numbers of new cases of over 50k/day.1 This is double the rate seen in mid-May with total cases now totaling 2.8m, up from 200k cases at the end of Q1.1 Reopening plans have been rolled back in many states. Generally, the level of uncertainty regarding the virus is growing, not falling. Despite this environment, risk assets enjoyed strong rallies throughout the quarter, leading to discussions of the disconnect between Main Street

HealthWatch: Probiotics

By Lineweaver Financial Group
July 16, 2020 Category: HealthWatch, Probiotics

Are you currently taking probiotics to improve your gut health? New research from the American Gastronenterological Association is showing that it might not be as helpful as we are led to believe. Since researchers started to learn more about our gut bacteria, or microbiome, probiotics have become more popular. Yogurt and dietary supplements contain certain bacteria and yeast, which are organisms found in probiotics. Depending on your location, you can find probiotics sold over the counter or by prescription. Since probiotics are not considered drugs in the United States, they arent regulated in the same way as other pharmaceutical products. This can lead to an increase in misleading information and has acted as a barrier to scientific research when it comes to how helpful probiotics actually are. For example, research has found there isnt enough evidence that suggests the use of probiotics to treat Crohns disease, ulcerative colitis, or IBS. The American Gastronenterological Association

Categories
Newsletter (27)
General (22)
Economic Commentary (15)
Letter From The President (14)
Retirement Planning (14)
Retirement (14)
Financial Planning (11)
Tax (11)
Healthwatch (10)
Lineweaver (10)
Market Commentary (8)
Q3 (7)
Taxes (7)
Tax Planning (6)
Education Programs (6)
Market (5)
Bonds (4)
LFG (4)
IRA (4)
Estate Planning (4)
Social Security (4)
Finance (3)
Trump (3)
Diversification (3)
Tax Law (3)
Portfolio (3)
(3)
Insurance (3)
2017 (3)
Market Review (3)
Tax Cuts And Jobs Act (2)
Investing (2)
Client Spotlight (2)
Stocks (2)
Rising Interest Rates (2)
Annuity (2)
Annuities (2)
Health (2)
Q2 Newsletter (2)
Market Update (2)
Charity (2)
Tax Scams (2)
Financial (2)
Coordination (2)
2019 (2)
Financial Strategies (2)
Brexit Update (2)
Interest Rates (2)
Investments (2)
2016 (2)
High Income (2)
Social Security Benefits (2)
Jim Lineweaver (1)
Bitcoin (1)
Investment (1)
New Years Resolutions (1)
Cooking (1)
Healthy (1)
Advice (1)
Tips (1)
Cryptocurrency (1)
Q1 (1)
Pro Football Hall Of Fame (1)
Market Volatility (1)
Drink Water (1)
Financial Goals (1)
Financial Quarterback (1)
Summer (1)
Vacation From Investments (1)
Quarterly Newsletter (1)
David Baker (1)
James Lineweaver (1)
Exercising (1)
Eye Strain (1)
Screens (1)
Vacation Home (1)
2018 (1)
Marital Trust (1)
Bloodline Trust (1)
Trusts (1)
Inheritance (1)
In Laws (1)
Market Outlook (1)
Q3 Newsletter (1)
Anne Graffice (1)
Statements (1)
Sring Cleaning Your Finances (1)
CARES Act (1)
POA (1)
Power Of Attorney (1)
Charitable (1)
Donations (1)
End Of Year Taxes (1)
Tax Strategies (1)
Black Swan (1)
CARES (1)
Stimulus (1)
Healthcare (1)
Nutrition (1)
Strategies (1)
Volatile Market (1)
Steps (1)
HealthWatch (1)
Probiotics (1)
Economic Outlook (1)
2020 (1)
Elder Law (1)
Longterm Care (1)
Keeping Your Mind Sharp (1)
Sell In May And Go Away (1)
Q2 2019 (1)
Legal (1)
Wills (1)
Chad Roope (1)
Roth Ira (1)
Roth Conversion (1)
Traditional Ira (1)
Congress (1)
Stock (1)
Banking (1)
Buy (1)
Sell (1)
Dementia (1)
Review (1)
Credit Unions (1)
Pse (1)
Big Banks (1)
Savings (1)
Checking (1)
Markets (1)
Tax Cuts (1)
Travel (1)
Life Insurance (1)
Retire (1)
Retire Early (1)
Legacy (1)
Retiring (1)
Self Employed (1)
Business Owners (1)
Annuity Alternatives (1)
Dividend (1)
Winter 2017 (1)
Bonds Ladder (1)
Policy (1)
Roth (1)
Donor Advised Fund (1)
Private Foundation Charitable Lead Trust (1)
Charitable Remainder Trust (1)
Growing Your Wealth (1)
Q1 2017 Newsletter (1)
2016 Market (1)
REITs (1)
Harvest For Hunger (1)
Retirement Tips (1)
Financial Advice (1)
Financial Advisor (1)
Social Security Planning (1)
Charitable Contributions (1)
Women And Money (1)
Service Day (1)
Gifting (1)
1st Quarter (1)
Election (1)
Candidates (1)
Politics (1)
Fall 2016 (1)
Financial Health (1)
Holiday Planning (1)
Stockpile (1)
Holiday Gifts (1)
Real Estate (1)
Risk Management (1)
Travel Tips (1)
Distribution (1)
Letter From The President New Years Resolutions (1)
Transfer Real Estate (1)
Defer Tax (1)
Top Financial Strategies Of The Wealthy (1)
Market Pullback (1)
Reallocation (1)
RMD (1)
Tariffs (1)
Eat More (1)
NAFTA (1)
Trading (1)
New Tax Law (1)
529 Plans (1)
Charitable Giving (1)
Q2 (1)
New Website (1)
Bruce Motko (1)
Market Review 2017 (1)
Lose Weight (1)
Protection (1)
Equifax (1)
North Korea (1)
Conflict (1)
Lineweaver Wealth Advisors (1)
Mutual Funds (1)
Expense (1)
Costs (1)
401(k) (1)
Mark Sipos (1)
Jobs (1)
2017 Q4 (1)
Fraud (1)
Identity Theft (1)
Third Quarter (1)
Tax Cuts And Job Act (1)
Introducing (1)
Kids (1)
Grand Kids (1)
2020Q3 (1)
+ Show More

Terms and Conditions | Privacy Policy | Disclosures

Lineweaver Financial Group ©
Powered by Virteom Logo Virteom